CP55,940 attenuates spatial memory retrieval in mice.

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Cannabinoids are lipophilic compounds affecting neuronal processes and cognitive function.
• Clinical and experimental data suggest cannabinoids negatively impact cognition.
• This study investigates the effects of a synthetic cannabinoid receptor agonist on spatial memory.

Purpose of the Study:

• To determine the influence of CP55,940 on spatial memory retrieval.
• To assess the dose-dependent effects of CP55,940 on cognitive processes.
• To differentiate cognitive impairment from motor effects of CP55,940.

Main Methods:

• Male C57BL/6J mice were trained in the Morris water maze for spatial memory assessment.
• CP55,940 was administered intraperitoneally at doses of 0.025, 0.125, or 0.25 mg/kg.
• Psychomotor activity and anxiety were evaluated using the hole-board test.

Main Results:

• The highest dose (0.25 mg/kg) of CP55,940 significantly impaired spatial memory retrieval.
• This impairment included increased latency to target, reduced target crossings, and less time in the target quadrant.
• Lower doses (0.125 mg/kg) attenuated motor and exploratory activity without affecting memory retrieval.

Conclusions:

• The highest dose of CP55,940 (0.25 mg/kg) impaired spatial memory, likely through cognitive mechanisms.
• While motor activity was reduced at 0.125 mg/kg, memory retrieval remained intact.
• The study suggests dose-dependent cognitive effects of cannabinoid receptor agonists, though motor impacts cannot be entirely excluded.